T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Financials | 11.46% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Molina Healthcare
MOH
$10.8B
| $693M | 0.08% |
3,783,633
+621,320
| +20% | +$113M |
|
252
Corning
GLW
$144B
| $689M | 0.08% |
21,261,669
-4,656,876
| -18% | -$144M |
|
253
Ultragenyx Pharmaceutical
RARE
$2.65B
| $686M | 0.08% |
8,348,729
+682,112
| +9% | +$56.5M |
|
254
XP
XP
$7.98B
| $685M | 0.08% |
16,435,442
+3,835,059
| +30% | +$175M |
|
255
Descartes Systems
DSGX
$6.65B
| $682M | 0.08% |
11,980,118
-706,152
| -6% | -$39.1M |
|
256
Assurant
AIZ
$13.9B
| $675M | 0.08% |
5,563,058
-52,180
| -0.9% | -$5.99M |
|
257
Equity Residential
EQR
$24.2B
| $673M | 0.08% |
13,106,239
+13,211
| +0.1% | +$731K |
|
|
ETFC
258
DELISTED
E*Trade Financial Corporation
ETFC
| $669M | 0.08% |
13,370,109
-42,350
| -0.3% | -$2.21M |
|
259
CarMax
KMX
$8.33B
| $668M | 0.08% |
7,268,225
-2,991,702
| -29% | -$299M |
|
260
GSK
GSK
$101B
| $666M | 0.08% |
14,150,606
+51,860
| +0.4% | +$2.6M |
|
261
Baidu
BIDU
$35.6B
| $665M | 0.08% |
5,250,034
+835,060
| +19% | +$103M |
|
262
Air Products & Chemicals
APD
$67.7B
| $658M | 0.08% |
2,209,378
-957,510
| -30% | -$275M |
|
|
PPLI
263
People Inc
PPLI
$3.02B
| $657M | 0.08% |
10,047,111
-59,829,272
| -86% | -$4.1B |
|
264
Loews
L
$23.1B
| $657M | 0.08% |
18,894,326
+1,731,140
| +10% | +$62.1M |
|
265
CF Industries
CF
$18.2B
| $656M | 0.08% |
21,365,664
+690,648
| +3% | +$22M |
|
266
Skyworks Solutions
SWKS
$10.5B
| $654M | 0.08% |
4,495,966
-1,160,551
| -21% | -$161M |
|
267
Crown Castle
CCI
$31.5B
| $646M | 0.07% |
3,879,604
-889,234
| -19% | -$147M |
|
268
Williams Companies
WMB
$90.1B
| $645M | 0.07% |
32,805,614
+6,470,713
| +25% | +$132M |
|
269
MarketAxess Holdings
MKTX
$5.72B
| $639M | 0.07% |
1,326,874
-18,677
| -1% | -$9.23M |
|
|
NVRO
270
DELISTED
NEVRO CORP.
NVRO
| $636M | 0.07% |
4,563,775
-331,433
| -7% | -$44.3M |
|
271
Mercado Libre
MELI
$92.7B
| $631M | 0.07% |
582,847
-441,992
| -43% | -$480M |
|
272
KKR & Co
KKR
$99.5B
| $623M | 0.07% |
18,138,533
-20,773
| -0.1% | -$727K |
|
273
Neurocrine Biosciences
NBIX
$15.9B
| $618M | 0.07% |
6,421,738
-257,855
| -4% | -$29.8M |
|
274
Envista
NVST
$4.61B
| $613M | 0.07% |
24,837,910
+1,861,434
| +8% | +$42.9M |
|
275
Rockwell Automation
ROK
$50.1B
| $610M | 0.07% |
2,765,890
-192,468
| -7% | -$43M |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.